PSA - 2019 Universal Registration Document

INFORMATION ABOUT THE COMPANY AND ITS SHARE CAPITAL Corporate financial instrument markets

CORPORATE FINANCIAL INSTRUMENT 7.4. MARKETS

LISTING OF THE PEUGEOT S.A. SHARE

The PeugeotS.A. share is listed on the EuronextParis stock exchange,compartment A,where it is eligible for the deferredsettlement system. PEUGEOTS.A. SHAREDATASHEET

ISINsecuritycode

FR0000121501

Euronext continuous trading – EuronextParis, Compartment A Ticker UGFP (Bloomberg) Other markets: Europe: SEAQ International – London > CAC 40,CACALL-TRADABLE, CAC LARGE 60, Dow Jones EuroStoxxAuto, AdvancedSustainablePerformance Indices(ASPI), FTSE4Good underthe SDRSystem and inclusion i French PEA stock savings plans

Markets

Listedin the major indexes Share eligibility

Deferred settlement

Par value

€1

Numberof shares outstanding at 31 December 2019 Price at 31 December 2019

904,828,213

€21.30 Market capitalisation at 31 December 2019 €19.27 billion

Groupe PSAhas opted not to institute or sponsor an American properlyor bound to protect the rights of ADR holders. Peugeot Depositary Receipt (ADR) programme. Thus any existing ADR S.A. rejects any liability and representsthat it does not recognise programme is classified as unsponsoredand has no connection any courtshavingjurisdiction,particularlyin the UnitedStates,with whatsoeverwith Groupe PSA.Consequently,Peugeot S.A. cannot respectto suchprogrammes. be considered bound to ensure that such programmesoperate DETAILED STOCK MARKET INFORMATION

(Source: Euronext) PRICE

2019

2018

% change on 2019/2018 closing price

High

Low 31/12/2018

High

Low 31/12/2018

(in euros)

Share

27.060 17.870 21.300 25.400 16.455 18.645 6,065.00 4,606.20 5,978.06 5,640.10 4,598.61 4,730.69

+14% +26%

CAC 40 index

TRANSACTIONS

2019

2018

Total

Average per day

Total

Average per day

In number of shares Value (in million euros)

657,518,050

2,576,481

791,183,768

3,177,444

14,523.82

56.91

16,167.88

64.93

303

GROUPE PSA - 2019 UNIVERSAL REGISTRATION DOCUMENT